IHH Healthcare Bhd co-led a minority investment in Singapore- based telehealth company Doctor Anywhere (DA), as part of DA’s US$27 million (RM116.3 million) Series B round to expand its platform and enter new geographies in South-East Asia.
The investment is in line with IHH’s strategy to partner innovative companies that deploy cutting-edge healthcare technology.
The healthcare provider noted in a release yesterday its aim is to enhance patient’s experience, treatment and clinical outcomes across its network of 77 hospitals in 10 countries.
IHH MD and CEO Dr Kelvin Loh said the partnership is immediately synergistic in Singapore, which is one of the group’s home markets.
“IHH is transforming healthcare to make it as convenient as possible for our patients.
“As part of this journey, IHH is very pleased to partner DA. Their end-to-end digital platform enables patients to schedule and receive virtual consultations with a doctor anytime, anywhere. Pre- scribed medications can also be delivered right to their home,” he said in a statement yesterday.
The partnership with DA will enable IHH to expand its digital ecosystem and better support clients with IHH’s full suite of healthcare services.
DA currently serves more than one million users, with mobile app users in Singapore and Thailand, as well as key Vietnamese cities of Hanoi and Ho Chi Minh.
“IHH brings to us their outstanding track record in delivering exceptional patient care and experience.
“With their strong global healthcare services network and deep pool of expertise, we are confident we will complement each other to make quality healthcare more accessible to patients in the region,” DA founder and CEO Lim Wai Mun said.